Effect of statins on atherogenic serum amyloid A and α1-antitrypsin low-density lipoprotein complexes
- 3 October 2016
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 225, 332-336
Abstract
No abstract availableKeywords
Funding Information
- Medical Research Program of the Shizuoka Prefectural Hospital Organization
This publication has 27 references indexed in Scilit:
- The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review)Vascular Pharmacology, 2015
- Effects of Statins on Left Ventricular Diastolic Function in Patients with Dyslipidemia and Diastolic Dysfunction (Stat-LVDF Study)Biological and Pharmaceutical Bulletin, 2015
- The effects of weight gain after smoking cessation on atherogenic α1-antitrypsin–low-density lipoproteinHeart and Vessels, 2014
- The potential of serum amyloid A–LDL as a novel biomarker for cardiovascular disease riskClinical Lipidology, 2010
- Influence of Statins on Glucose Tolerance in Patients with Type 2 Diabetes Mellitus: Subanalysis of the Collaborative Study on Hypercholesterolemia Drug Intervention and their Benefits for Atherosclerosis Prevention (CHIBA Study)Journal of Atherosclerosis and Thrombosis, 2009
- Influence of Pitavastatin on Glucose Tolerance in Patients with Type 2 Diabetes MellitusJournal of Atherosclerosis and Thrombosis, 2008
- Experimental and Clinical Basis for the Use of Statins in Patients With Ischemic and Nonischemic CardiomyopathyJACC, 2008
- Acute phase reaction and acute phase proteinsJournal of Zhejiang University-SCIENCE B, 2005
- In Vivo Complex Formation of Oxidized α 1 -Antitrypsin and LDLArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Activation of Primary Human Monocytes by the Oxidized Form of α1-AntitrypsinJournal of Biological Chemistry, 2000